Eintrag weiter verarbeiten
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest?
Gespeichert in:
Zeitschriftentitel: | Epilepsia |
---|---|
Personen und Körperschaften: | |
In: | Epilepsia, 49, 2008, s9, S. 43-55 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
author_facet |
Pennell, Page B. Pennell, Page B. |
---|---|
author |
Pennell, Page B. |
spellingShingle |
Pennell, Page B. Epilepsia Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? Neurology (clinical) Neurology |
author_sort |
pennell, page b. |
spelling |
Pennell, Page B. 0013-9580 1528-1167 Wiley Neurology (clinical) Neurology http://dx.doi.org/10.1111/j.1528-1167.2008.01926.x <jats:title>Summary</jats:title><jats:p>Most infants born to women with epilepsy are healthy, but there are increased risks related to in utero antiepileptic drug (AED) exposure and seizures. Emerging data from pregnancy registries and other studies allow us to better balance the anatomic teratogenic and neurodevelopmental effects of AEDs against the need to maintain maternal seizure control. Several large prospective pregnancy registries demonstrate a consistent pattern of increased risk for major congenital malformations (MCMs) with valproate (VPA) use as monotherapy, compared to nonexposed populations and to other AEDs used in monotherapy. AED polytherapy likely increases risk for MCMs, but the risk is more pronounced if VPA is included. Reduced cognitive outcomes have been reported with AED polytherapy, and with use of VPA, phenobarbital (PB), and PHT as monotherapy. Dose‐dependent risk has been demonstrated with VPA for MCMs and cognitive consequences. CBZ groups show normal neurodevelopment. Increased clearance of most of the AEDs occurs during pregnancy. Use of therapeutic drug monitoring during pregnancy with LTG reduces the risk for seizure worsening. The consistent findings of increased teratogenic risk for VPA should discourage use of this medication as first‐line treatment in women of childbearing age.</jats:p> Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? Epilepsia |
doi_str_mv |
10.1111/j.1528-1167.2008.01926.x |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE1MjgtMTE2Ny4yMDA4LjAxOTI2Lng |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE1MjgtMTE2Ny4yMDA4LjAxOTI2Lng |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
Wiley, 2008 |
imprint_str_mv |
Wiley, 2008 |
issn |
0013-9580 1528-1167 |
issn_str_mv |
0013-9580 1528-1167 |
language |
English |
mega_collection |
Wiley (CrossRef) |
match_str |
pennell2008antiepilepticdrugsduringpregnancywhatisknownandwhichaedsseemtobesafest |
publishDateSort |
2008 |
publisher |
Wiley |
recordtype |
ai |
record_format |
ai |
series |
Epilepsia |
source_id |
49 |
title |
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_unstemmed |
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_full |
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_fullStr |
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_full_unstemmed |
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_short |
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_sort |
antiepileptic drugs during pregnancy: what is known and which aeds seem to be safest? |
topic |
Neurology (clinical) Neurology |
url |
http://dx.doi.org/10.1111/j.1528-1167.2008.01926.x |
publishDate |
2008 |
physical |
43-55 |
description |
<jats:title>Summary</jats:title><jats:p>Most infants born to women with epilepsy are healthy, but there are increased risks related to in utero antiepileptic drug (AED) exposure and seizures. Emerging data from pregnancy registries and other studies allow us to better balance the anatomic teratogenic and neurodevelopmental effects of AEDs against the need to maintain maternal seizure control. Several large prospective pregnancy registries demonstrate a consistent pattern of increased risk for major congenital malformations (MCMs) with valproate (VPA) use as monotherapy, compared to nonexposed populations and to other AEDs used in monotherapy. AED polytherapy likely increases risk for MCMs, but the risk is more pronounced if VPA is included. Reduced cognitive outcomes have been reported with AED polytherapy, and with use of VPA, phenobarbital (PB), and PHT as monotherapy. Dose‐dependent risk has been demonstrated with VPA for MCMs and cognitive consequences. CBZ groups show normal neurodevelopment. Increased clearance of most of the AEDs occurs during pregnancy. Use of therapeutic drug monitoring during pregnancy with LTG reduces the risk for seizure worsening. The consistent findings of increased teratogenic risk for VPA should discourage use of this medication as first‐line treatment in women of childbearing age.</jats:p> |
container_issue |
s9 |
container_start_page |
43 |
container_title |
Epilepsia |
container_volume |
49 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792343567230828545 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:53:46.095Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Antiepileptic+drugs+during+pregnancy%3A+What+is+known+and+which+AEDs+seem+to+be+safest%3F&rft.date=2008-12-01&genre=article&issn=1528-1167&volume=49&issue=s9&spage=43&epage=55&pages=43-55&jtitle=Epilepsia&atitle=Antiepileptic+drugs+during+pregnancy%3A+What+is+known+and+which+AEDs+seem+to+be+safest%3F&aulast=Pennell&aufirst=Page+B.&rft_id=info%3Adoi%2F10.1111%2Fj.1528-1167.2008.01926.x&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792343567230828545 |
author | Pennell, Page B. |
author_facet | Pennell, Page B., Pennell, Page B. |
author_sort | pennell, page b. |
container_issue | s9 |
container_start_page | 43 |
container_title | Epilepsia |
container_volume | 49 |
description | <jats:title>Summary</jats:title><jats:p>Most infants born to women with epilepsy are healthy, but there are increased risks related to in utero antiepileptic drug (AED) exposure and seizures. Emerging data from pregnancy registries and other studies allow us to better balance the anatomic teratogenic and neurodevelopmental effects of AEDs against the need to maintain maternal seizure control. Several large prospective pregnancy registries demonstrate a consistent pattern of increased risk for major congenital malformations (MCMs) with valproate (VPA) use as monotherapy, compared to nonexposed populations and to other AEDs used in monotherapy. AED polytherapy likely increases risk for MCMs, but the risk is more pronounced if VPA is included. Reduced cognitive outcomes have been reported with AED polytherapy, and with use of VPA, phenobarbital (PB), and PHT as monotherapy. Dose‐dependent risk has been demonstrated with VPA for MCMs and cognitive consequences. CBZ groups show normal neurodevelopment. Increased clearance of most of the AEDs occurs during pregnancy. Use of therapeutic drug monitoring during pregnancy with LTG reduces the risk for seizure worsening. The consistent findings of increased teratogenic risk for VPA should discourage use of this medication as first‐line treatment in women of childbearing age.</jats:p> |
doi_str_mv | 10.1111/j.1528-1167.2008.01926.x |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE1MjgtMTE2Ny4yMDA4LjAxOTI2Lng |
imprint | Wiley, 2008 |
imprint_str_mv | Wiley, 2008 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 0013-9580, 1528-1167 |
issn_str_mv | 0013-9580, 1528-1167 |
language | English |
last_indexed | 2024-03-01T16:53:46.095Z |
match_str | pennell2008antiepilepticdrugsduringpregnancywhatisknownandwhichaedsseemtobesafest |
mega_collection | Wiley (CrossRef) |
physical | 43-55 |
publishDate | 2008 |
publishDateSort | 2008 |
publisher | Wiley |
record_format | ai |
recordtype | ai |
series | Epilepsia |
source_id | 49 |
spelling | Pennell, Page B. 0013-9580 1528-1167 Wiley Neurology (clinical) Neurology http://dx.doi.org/10.1111/j.1528-1167.2008.01926.x <jats:title>Summary</jats:title><jats:p>Most infants born to women with epilepsy are healthy, but there are increased risks related to in utero antiepileptic drug (AED) exposure and seizures. Emerging data from pregnancy registries and other studies allow us to better balance the anatomic teratogenic and neurodevelopmental effects of AEDs against the need to maintain maternal seizure control. Several large prospective pregnancy registries demonstrate a consistent pattern of increased risk for major congenital malformations (MCMs) with valproate (VPA) use as monotherapy, compared to nonexposed populations and to other AEDs used in monotherapy. AED polytherapy likely increases risk for MCMs, but the risk is more pronounced if VPA is included. Reduced cognitive outcomes have been reported with AED polytherapy, and with use of VPA, phenobarbital (PB), and PHT as monotherapy. Dose‐dependent risk has been demonstrated with VPA for MCMs and cognitive consequences. CBZ groups show normal neurodevelopment. Increased clearance of most of the AEDs occurs during pregnancy. Use of therapeutic drug monitoring during pregnancy with LTG reduces the risk for seizure worsening. The consistent findings of increased teratogenic risk for VPA should discourage use of this medication as first‐line treatment in women of childbearing age.</jats:p> Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? Epilepsia |
spellingShingle | Pennell, Page B., Epilepsia, Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest?, Neurology (clinical), Neurology |
title | Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_full | Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_fullStr | Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_full_unstemmed | Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_short | Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
title_sort | antiepileptic drugs during pregnancy: what is known and which aeds seem to be safest? |
title_unstemmed | Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest? |
topic | Neurology (clinical), Neurology |
url | http://dx.doi.org/10.1111/j.1528-1167.2008.01926.x |